Phalaris arundinacea pollen
Star0
Identification
- Summary
-
Phalaris arundinacea pollenis an extract from Phalaris arundinacea pollen used in allergy testing.
- Generic Name
- Phalaris arundinacea pollen
- DrugBank Accession Number
- DB10714
- Background
-
Phalaris arundinacea pollen is the pollen of the Phalaris arundinacea plant. Phalaris arundinacea pollen is mainly used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
-
Allergenics
Allergen Extract - Synonyms
-
- canary grass pollen extract
Pharmacology
- Indication
-
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning models
with evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets. - Contraindications & Blackbox Warnings
-
Avoid life-threatening adverse drug eventsImprove clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
-
Not Available
- Mechanism of action
- Not Available
- Absorption
-
Not Available
- Volume of distribution
-
Not Available
- Protein binding
-
Not Available
- Metabolism
- Not Available
- Route of elimination
-
Not Available
- Half-life
-
Not Available
- Clearance
-
Not Available
- Adverse Effects
-
Improve decision support & research outcomesWith structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
-
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
-
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcebutolol The risk of a hypersensitivity reaction to Phalaris arundinacea pollen is increased when it is combined with Acebutolol. Atenolol The risk of a hypersensitivity reaction to Phalaris arundinacea pollen is increased when it is combined with Atenolol. Benazepril The risk or severity of adverse effects can be increased when Benazepril is combined with Phalaris arundinacea pollen. Betaxolol The risk of a hypersensitivity reaction to Phalaris arundinacea pollen is increased when it is combined with Betaxolol. Bisoprolol The risk of a hypersensitivity reaction to Phalaris arundinacea pollen is increased when it is combined with Bisoprolol. Captopril The risk or severity of adverse effects can be increased when Captopril is combined with Phalaris arundinacea pollen. Carvedilol The risk of a hypersensitivity reaction to Phalaris arundinacea pollen is increased when it is combined with Carvedilol. Celiprolol The risk of a hypersensitivity reaction to Phalaris arundinacea pollen is increased when it is combined with Celiprolol. Cilazapril The risk or severity of adverse effects can be increased when Cilazapril is combined with Phalaris arundinacea pollen. Enalapril The risk or severity of adverse effects can be increased when Enalapril is combined with Phalaris arundinacea pollen. Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Not Available
Products
-
Drug product information from 10+ global regionsOur datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions. - Brand Name Prescription Products
-
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Canary Grass Injection, solution 40000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Canary Grass Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Canary Grass Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Canary Grass Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Canary Grass Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Canary Grass Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Canary Grass Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Canary Grass Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Canary Grass Pollen Injection 0.05 g/1mL Cutaneous; Intradermal; Subcutaneous Allermed Laboratories, Inc. 1974-03-12 Not applicable US Reed Canary Grass Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-03-23 Not applicable US - Mixture Products
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- FAY1Y90VJ9
- CAS number
- Not Available
References
Clinical Trials
- Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
-
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
-
Not Available
- Packagers
-
Not Available
- Dosage Forms
-
Form Route Strength Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Injection Cutaneous; Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53